GKIM
GWPH

GW&K Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

GW&K Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60
Closed -$13K – 421
2021
Q1 		$13K Sell
60
-53,513
-100% -$10.1M ﹤0.01% 364
2020
Q4 		$6.18M Sell
53,573
-845
-2% -$94.7K 0.06% 247
2020
Q3 		$5.3M Sell
54,418
-918
-2% -$106K 0.07% 237
2020
Q2 		$6.79M Sell
55,336
-1,247
-2% -$141K 0.1% 223
2020
Q1 		$4.96M Buy
56,583
+390
+0.7% +$41.3K 0.09% 217
2019
Q4 		$5.88M Buy
56,193
+18,448
+49% +$2.07M 0.08% 229
2019
Q3 		$4.34M Buy
37,745
+11,474
+44% +$1.74M 0.06% 252
2019
Q2 		$4.53M Sell
26,271
-269
-1% -$46.5K 0.07% 252
2019
Q1 		$4.47M Sell
26,540
-4,056
-13% -$604K 0.07% 223
2018
Q4 		$2.98M Buy
+30,596
New +$4.01M 0.06% 217

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

GW&K Investment Management's GWPH Position: Q2 2021 in Review

GW&K Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 60 shares — an estimated $13K sold.

GW&K Investment Management first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $6.79M in Q2 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • GW&K Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • GW&K Investment Management sold 60 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $13K.
  • GW&K Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
  • GW&K Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6.79M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on GW&K Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.